Gene Silencing is a sophisticated molecular mechanism that regulates gene expression by preventing the synthesis of specific proteins encoded by certain genes. This process is crucial for maintaining cellular homeostasis, development, and response to environmental stimuli. Various mechanisms underlie gene silencing, with RNA interference (RNAi) being a prominent one. In RNAi, small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs), guide the degradation or translational repression of target messenger RNAs (mRNAs). Another mechanism involves epigenetic modifications, where chemical alterations to DNA or associated histone proteins inhibit gene transcription. Gene silencing plays a pivotal role in controlling the activity of transposons, repetitive sequences, and regulating cellular processes like differentiation and immune response. Harnessing gene silencing technologies has significant implications for medicine, as it can be employed to treat genetic disorders, viral infections, and certain cancers by selectively inhibiting the expression of disease-associated genes. While the potential therapeutic applications are promising, challenges such as specificity, delivery methods, and off-target effects continue to be addressed in ongoing research. As our understanding of gene silencing mechanisms deepens, so does the potential for targeted interventions in diverse fields, from personalized medicine to agriculture.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy